D. van Baarle

714 citations

21 papers · 562 · h-index 11

Impact in

Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Epidemiology top 10%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments

Papers in

Epidemiology 14
- Cytomegalovirus and herpesvirus research 9
- Herpesvirus Infections and Treatments 4
- Hepatitis B Virus Studies 3
Immunology 12
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 5

Co-authors: Nening M. Nanlohy (8 shared papers)Suzanne van Dorp (3 shared papers)Frank Miedema (2 shared papers)Jürgen Kuball (2 shared papers)Erwan Piriou (2 shared papers)Bodo Plachter (1 shared paper)Wouter Scheper (1 shared paper)David Vermijlen (1 shared paper)
Journals: Clinical Infectious Diseases (4 papers)Journal of Viral Hepatitis (3 papers)Bone Marrow Transplantation (2 papers)Leukemia (2 papers)Clinical Immunology (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

D. van Baarle

21 papers receiving 549 citations

Peers

Countries citing papers authored by D. van Baarle

Since Specialization

Citations

This map shows the geographic impact of D. van Baarle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van Baarle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van Baarle more than expected).

Fields of papers citing papers by D. van Baarle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. van Baarle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van Baarle. The network helps show where D. van Baarle may publish in the future.

Co-authors

The 25 scholars most cited alongside D. van Baarle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. van Baarle Line = papers co-authored together D. van Baarle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia Leukemia ·Wouter Scheper, Suzanne van Dorp, Sabina Kersting, Floor Pietersma, Caroline A. Lindemans, Samantha Hol, Sabine Heijhuurs, Zsolt Sebestyén, C. Gründer, Victoria Marcu‐Malina, Arnaud Marchant, Catherine Donner, Bodo Plachter, David Vermijlen, D. van Baarle, Jürgen Kuball	2013	149
2	Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia Clinical & Experimental Immunology ·J.H.M. Visser, Hans W. Nijman, B-N Hoogenboom, Paul O. J. Jager, D. van Baarle, Ed Schuuring, Wayel H. Abdulahad, Frank Miedema, A. G. van der Zee, Toos Daemen	2007	72
3	Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity Clinical Microbiology and Infection ·Jayne S. Sutherland, André G. Loxton, Mariëlle C. Haks, Desta Kassa, Lenuta Ambrose, Ji‐Sook Lee, L. Ran, D. van Baarle, Jeroen Maertzdorf, Rawleigh Howe, Harriet Mayanja‐Kizza, W. Henry Boom, Bonnie Thiel, Amelia C. Crampin, Willem A. Hanekom, Martin O. C. Ota, Hazel M. Dockrell, Gerhard Walzl, Stefan H. E. Kaufmann, Tom H. M. Ottenhoff	2013	58
4	Management of Epstein-Barr Virus (EBV) Reactivation after Allogeneic Stem Cell Transplantation by Simultaneous Analysis of EBV DNA Load and EBV-Specific T Cell Reconstitution Clinical Infectious Diseases ·Nicola Annels, Jayant Kalpoe, Robbert G. M. Bredius, Eric C. J. Claas, Aloys C.M. Kroes, Andrew D. Hislop, D. van Baarle, R. Maarten Egeler, Maarten J. D. van Tol, Arjan C. Lankester	2006	50
5	Dynamics of Cytomegalovirus (CMV)–Specific T Cells in HIV‐1–Infected Individuals Progressing to AIDS with CMV End‐Organ Disease The Journal of Infectious Diseases ·C. Bronke, N. Palmer, Christine A. Jansen, Geertje H. A. Westerlaken, Abeltje M. Polstra, Peter Reiss, Margreet Bakker, Frank Miedema, Kiki Tesselaar, D. van Baarle	2005	49
6	Detailed analysis of Epstein–Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis Clinical & Experimental Immunology ·Jolanda Scherrenburg, Erwan Piriou, Nening M. Nanlohy, D. van Baarle	2008	36
7	Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1 Leukemia ·Rimke Oostvogels, Monique C. Minnema, Maureen van Elk, Robbert M. Spaapen, G. Doreen te Raa, Barbara Giovannone, Arjan Buijs, D. van Baarle, A. P. Kater, Marieke Griffioen, Eric Spierings, H M Lokhorst, Tuna Mutis	2012	22
8	Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT Bone Marrow Transplantation ·P.J.A. de Pagter, Rob Schuurman, L. Keukens, Martin Schutten, Jan J. Cornelissen, D. van Baarle, Edwin Fries, Elisabeth A. M. Sanders, Monique C. Minnema, Bronno van der Holt, Ellen Meijer, Jaap Jan Boelens	2013	21
9	Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients Clinical Infectious Diseases ·Floor Pietersma, Suzanne van Dorp, Monique C. Minnema, Jürgen Kuball, Ellen Meijer, Rob Schuurman, D. van Baarle	2011	17
10	HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance Journal of Viral Hepatitis ·Th. A. Ruys, Nening M. Nanlohy, Charlotte H. S. B. van den Berg, Elly A. Hassink, Marcel Beld, Teus van Laar, Sylvia M. Bruisten, Ferdinand Wit, Anneke Krol, Maria Prins, Joep M. A. Lange, D. van Baarle	2008	16
11	Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells APOPTOSIS ·Joop E. Arends, A. I. M. Hoepelman, Nening M. Nanlohy, F. Höppener, Kenneth Hirsch, J. G. Park, D. van Baarle	2011	11
12	Tight Regulation of the Epstein-Barr Virus Setpoint: Interindividual Differences in Epstein-Barr Virus DNA Load Are Conserved after HIV Infection Clinical Infectious Diseases ·Erwan Piriou, Karel van Dort, S Ottó, Marinus H. J. van Oers, D. van Baarle	2007	10
13	High Level of Perforin Expression in T Cells: An Early Prognostic Marker of the Severity of Herpesvirus Reactivation after Allogeneic Stem Cell Transplantation in Adults Clinical Infectious Diseases ·Floor Pietersma, Suzanne van Dorp, Ronald Jacobi, L. Ran, Nening M. Nanlohy, Rob Schuurman, Monique C. Minnema, Ellen Meijer, D. van Baarle	2010	9
14	Plasma HCV‐RNA decline in the first 48 h identifies hepatitis C virus mono‐infected but not HCV/HIV‐coinfected patients with an undetectable HCV viral load at week 4 of peginterferon‐alfa‐2a/ribavirin therapy Journal of Viral Hepatitis ·Joop E. Arends, James Cohen Stuart, Lubbertus C. Baak, Marc van der Valk, Karel J. van Erpecum, C. P. M. Simons, Greet J. Boland, D. van Baarle, Andy I. M. Hoepelman	2009	9
15	First analysis of human herpesvirus 6T-cell responses: Specific boosting after HHV6 reactivation in stem cell transplantation recipients Clinical Immunology ·Anne P.J. de Pagter, Jaap Jan Boelens, Jolanda Scherrenburg, T. Vroom-de Blank, Kiki Tesselaar, Nening M. Nanlohy, Elisabeth A. M. Sanders, Rob Schuurman, D. van Baarle	2012	8
16	Comprehensive longitudinal analysis of hepatitis C virus (HCV)‐specific T cell responses during acute HCV infection in the presence of existing HIV‐1 infection Journal of Viral Hepatitis ·Charlotte H. S. B. van den Berg, Th. A. Ruys, Nening M. Nanlohy, Suzanne E. Geerlings, J. T. van der Meer, Jan W. Mulder, JoepM.A. Lange, D. van Baarle	2009	7
17	Increased proportion of perforin-expressing CD8+T-cells indicates control of herpesvirus reactivation in children after stem cell transplantation Clinical Immunology ·P.J. de Pagter, Jaap Jan Boelens, Ronald Jacobi, Rob Schuurman, Nening M. Nanlohy, Elisabeth A. M. Sanders, D. van Baarle	2013	6
18	Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient Transplant Immunology ·Floor Pietersma, A. van Oosterom, L. Ran, Rob Schuurman, Ellen Meijer, Nicolaas de Jonge, D. van Baarle	2012	5
19	Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease Bone Marrow Transplantation ·Lieke Reubsaet, Anne P.J. de Pagter, D. van Baarle, L. Keukens, Nening M. Nanlohy, Elisabeth A. M. Sanders, Berent J. Prakken, Jaap Jan Boelens, I. M. de Kleer	2012	4
20	Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection. International Journal of Molecular Medicine ·A. Samer Al‐Homsi, Christoph Berger, D. van Baarle, Marie José Kersten, Marina Klein, Cathy McQuain, RH van Oers, Hans Knecht	1998	2

About D. van Baarle

D. van Baarle is a scholar working on Epidemiology, Immunology, Oncology, Hepatology and Virology, having authored 21 papers that have together received 562 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Cytomegalovirus and herpesvirus research (9 papers), Viral-associated cancers and disorders (8 papers), Hepatitis C virus research (5 papers), T-cell and B-cell Immunology (5 papers), Herpesvirus Infections and Treatments (4 papers), HIV Research and Treatment (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Immunology (311 citations), Epidemiology (343 citations), Hematology (96 citations), Virology (35 citations) and Oncology (184 citations). D. van Baarle has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Nening M. Nanlohy, Suzanne van Dorp, Frank Miedema, Jürgen Kuball, Erwan Piriou, Bodo Plachter, Wouter Scheper, David Vermijlen, Caroline A. Lindemans and Catherine Donner. Their work appears in journals such as Clinical Infectious Diseases, Journal of Viral Hepatitis, Bone Marrow Transplantation, Leukemia and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D. van Baarle

Impact in

Papers in i

In The Last Decade

D. van Baarle

Peers

Countries citing papers authored by D. van Baarle

Fields of papers citing papers by D. van Baarle

All Works

About D. van Baarle

Explore authors with similar magnitude of impact

Papers in